Swiss pharmaceutical giant Novartis wants to double its business in China by 2024
(WorldNews Switzerland)

Swiss pharmaceutical giant Novartis said on Tuesday that its sales in China increased by double digits last year and planned to double its activities in China by 2024 compared to sales in 2019. “China is a top priority for Novartis,” Novartis CEO Vas Narasimhan said in an interview with Media. “As part of our strategic planning, we believe China will become the second-largest drug market for Novartis in the world. Our goal is to double our...